Omeros Corporation (OMER)

NASDAQ
15.76
+0.21(+1.35%)
After Hours
15.76
-0.02(-0.13%)
- Real-time Data
  • Volume:
    273,305
  • Bid/Ask:
    15.37/16.24
  • Day's Range:
    15.13 - 15.79

OMER Overview

Prev. Close
15.55
Day's Range
15.13-15.79
Revenue
86.62M
Open
15.49
52 wk Range
9.25-23.85
EPS
-2.29
Volume
273,305
Market Cap
971.81M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
400,661
P/E Ratio
-
Beta
1.12
1-Year Change
26.73%
Shares Outstanding
62,495,645
Next Earnings Date
Nov 11, 2021
What is your sentiment on Omeros Corporation?
or
Market is currently closed. Voting is open during market hours.

Omeros Corporation News

Omeros Corporation Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuySellNeutral
SummaryStrong BuyStrong BuyStrong BuyNeutralNeutral

Omeros Corporation Company Profile

Omeros Corporation Company Profile

Sector
Services
Employees
277

Omeros Corporation is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system. The Company’s drug product OMIDRIA (phenylephrine and ketorolac intraocular solution) is used during cataract surgery or intraocular lens (IOL) replacement. The Company’s clinical-stage development programs are focused on complement-associated thrombotic microangiopathies, complement-mediated glomerulonephropathies, Huntington’s disease and cognitive impairment, and addictive and compulsive disorders. It also offers a diverse group of preclinical programs and platforms that are used to unlock new G protein-coupled receptor (GPCR) drug targets and to generate antibodies.

Read More
  • This is just getting started folks.
    0
    • Well, It appers iits not ready to turn around. Based on what I see: The STOCH is starting to build momentum on the hourly; however, I would keep an eye out on the RSI, as this still does not have any strength. The Range I will be watching is bollinger bands: Low: $11.09 Mid:17.34. I will be holding to see whats going to take place. It appears a level of support is around $13.14. I am still in this trade, and I am learning to watch the stocks versus jumping into something that doesn't prove to have support just yet. It sure is a lot cheaper to watch versus throw in and cross fingers it will hold.
      0
      • down %12 good buy for small amount of shares?
        0
        • good buy or avoid?
          0
          • Based on what i see were in a up trend approaching a channel resistance of about $19. Im holding
            0
            • hold hold hold
              1
              • based on yesterday's slowness, I'm kinda hesitant to play with it. any suggestion gurus?
                0
                • Sell or hold???
                  0
                  • This thing going to ****up soon
                    0
                    • extremely undervalued, 9.4m shorts slowing it down. slow and steady is fine
                      0
                      • $OMER has all 7 analyst saying “BUY” with an ave 12 month target price of $37.33 which is 194% at its closing price of $12.71
                        0
                        • That is 194% ROI
                          0
                        • Funny I thought this was year 2020
                          0
                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.